Literature DB >> 24657837

Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy.

Ranjith Ramasamy1, Jason M Scovell1, Jason R Kovac1, Larry I Lipshultz2.   

Abstract

PURPOSE: We compared satisfaction and treatment efficacy in men with symptomatic hypogonadism who received clomiphene citrate or testosterone supplementation therapy.
MATERIALS AND METHODS: Men treated with clomiphene citrate, or testosterone injections or gels for symptomatic hypogonadism (total testosterone less than 300 ng/dl) reported satisfaction with the current treatment regimen using the qADAM questionnaire.
RESULTS: A total of 93 men on testosterone injections (31) or gels (31), or clomiphene citrate (31) were age matched from a retrospective cohort of 1,150 on testosterone supplementation therapy. We compared men who received testosterone supplementation therapy to 31 not on such therapy, who served as controls. Median serum testosterone increased from pretreatment levels in all men regardless of therapy with clomiphene citrate, and testosterone injections and gels (from 247 to 504, 224 to 1,104 and 230 to 412 ng/dl, respectively, p <0.05). Final median serum total testosterone in men on clomiphene citrate (504 ng/dl) was lower than in men receiving testosterone injections (1,014 ng/dl, p <0.01) but similar to that in men on testosterone gels (412 ng/dl, p = 0.31). Despite different serum testosterone levels men on all 3 therapies reported similar satisfaction on qADAM, including a score of 35 for clomiphene citrate, 39 for testosterone injections, 36 for testosterone gels and 34 for control treatment (p >0.05). Men receiving testosterone injections reported greater libido than men on clomiphene citrate (4 vs 3, p = 0.04) or testosterone gels (4 vs 3, p = 0.04), or controls (4 vs 3, p <0.01).
CONCLUSIONS: Testosterone supplementation regimens and clomiphene citrate are efficacious for improving serum total testosterone. No difference in overall hypogonadal symptoms was noted among men on any testosterone supplementation therapy. Despite lower serum total testosterone, men on clomiphene citrate and testosterone gels reported satisfaction similar to that of men treated with testosterone injections.
Copyright © 2014 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  clomiphene; hypogonadism; questionnaires; testes; testosterone

Mesh:

Substances:

Year:  2014        PMID: 24657837     DOI: 10.1016/j.juro.2014.03.089

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

1.  Reproductive endocrinology: Oral enclomiphene citrate in obese men with hypogonadism.

Authors:  Jason R Kovac
Journal:  Nat Rev Urol       Date:  2016-01-20       Impact factor: 14.432

Review 2.  Estrogens and Male Lower Urinary Tract Dysfunction.

Authors:  Jalissa L Wynder; Tristan M Nicholson; Donald B DeFranco; William A Ricke
Journal:  Curr Urol Rep       Date:  2015-09       Impact factor: 3.092

Review 3.  Review of health risks of low testosterone and testosterone administration.

Authors:  Huanguang Jia; Charles T Sullivan; Sean C McCoy; Joshua F Yarrow; Matthew Morrow; Stephen E Borst
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

4.  Is semen analysis necessary prior to the commencement of testosterone supplementation therapy in men of reproductive age?

Authors:  Michael Pan; Ranjith Ramasamy; Jason R Kovac
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

Review 5.  Diagnosis and treatment of infertility-related male hormonal dysfunction.

Authors:  Martin Kathrins; Craig Niederberger
Journal:  Nat Rev Urol       Date:  2016-04-19       Impact factor: 14.432

Review 6.  Treatment of hypogonadotropic male hypogonadism: Case-based scenarios.

Authors:  Lindsey E Crosnoe-Shipley; Osama O Elkelany; Cyrus D Rahnema; Edward D Kim
Journal:  World J Nephrol       Date:  2015-05-06

Review 7.  Sexual dysfunction and male infertility.

Authors:  Francesco Lotti; Mario Maggi
Journal:  Nat Rev Urol       Date:  2018-03-13       Impact factor: 14.432

Review 8.  Enclomiphene citrate for the treatment of secondary male hypogonadism.

Authors:  Katherine M Rodriguez; Alexander W Pastuszak; Larry I Lipshultz
Journal:  Expert Opin Pharmacother       Date:  2016-07-04       Impact factor: 3.889

Review 9.  Alternatives to testosterone replacement: testosterone restoration.

Authors:  Andrew McCullough
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

Review 10.  Preserving fertility in the hypogonadal patient: an update.

Authors:  Ranjith Ramasamy; Joseph M Armstrong; Larry I Lipshultz
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.